Nature Communications (Oct 2022)

Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer

  • Bihui Cao,
  • Manting Liu,
  • Lu Wang,
  • Kangshun Zhu,
  • Mingyue Cai,
  • Xiaopei Chen,
  • Yunfei Feng,
  • Shuo Yang,
  • Shengyu Fu,
  • Cheng Zhi,
  • Xiaodie Ye,
  • Jian Zhang,
  • Zhiru Zhang,
  • Xin Yang,
  • Ming Zhao,
  • Qingde Wu,
  • Linfeng Xu,
  • Lili Yang,
  • Hui Lian,
  • Qi Zhao,
  • Zhenfeng Zhang

DOI
https://doi.org/10.1038/s41467-022-33968-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

AXL is overexpressed and has been investigated as a therapeutic target in several cancer types, including lung cancer. Here the authors design AXLdirected CAR-T cells and show that their anti-tumor activity can be improved in combination with microwave ablation in preclinical lung cancer models.